-
Signature
-
/s/ James J. Comitale, as Attorney-in-Fact
-
Stock symbol
-
OLLI
-
Transactions as of
-
Jul 26, 2023
-
Transactions value $
-
-$1,623,858
-
Form type
-
4
-
Date filed
-
7/28/2023, 05:15 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
OLLI |
Common Stock, par value $0.001 per share |
Options Exercise |
$95K |
+4.69K |
+9.73% |
$20.26 |
52.9K |
Jul 26, 2023 |
Direct |
F1 |
transaction |
OLLI |
Common Stock, par value $0.001 per share |
Sale |
-$344K |
-4.69K |
-8.87% |
$73.26 |
48.2K |
Jul 26, 2023 |
Direct |
F1, F2 |
transaction |
OLLI |
Common Stock, par value $0.001 per share |
Options Exercise |
$524K |
+25.9K |
+53.65% |
$20.26 |
74.1K |
Jul 27, 2023 |
Direct |
F1 |
transaction |
OLLI |
Common Stock, par value $0.001 per share |
Sale |
-$1.9M |
-25.9K |
-34.92% |
$73.44 |
48.2K |
Jul 27, 2023 |
Direct |
F1, F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
OLLI |
Employee Stock Option (Right to Buy) |
Options Exercise |
$0 |
-4.69K |
-13.4% |
$0.00 |
30.3K |
Jul 26, 2023 |
Common Stock |
4.69K |
$20.26 |
Direct |
F1, F4 |
transaction |
OLLI |
Employee Stock Option (Right to Buy) |
Options Exercise |
$0 |
-25.9K |
-85.32% |
$0.00 |
4.45K |
Jul 27, 2023 |
Common Stock |
25.9K |
$20.26 |
Direct |
F1, F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: